Skip to the guide
EXACT 41

Neuroscience research / EDUCATIONAL GUIDE

Semax

Semax 10 mg box packaging mockup
Packaging mockup
10 mg€29.90

Research aims, observed effects
and the limits of the evidence.

Animal evidence focusSources checked 6 September 2026

THE IDEA IN EVERYDAY TERMS

How the brain responds to injury

Semax is studied in neuroscience, including experiments in which blood flow to part of the brain is reduced. Researchers ask whether it changes the biological response to that injury. In the rat study reviewed here, they measured which genes became more or less active, including genes involved in immune responses.

Read the background ↗

Brain-injury model in rats

What has actually been shown?

The study found changes in immune-related gene activity after Semax treatment. These findings may help researchers investigate how nerve tissue responds to injury. They are not a test of concentration or everyday memory in healthy people, and do not establish Semax as an effective stroke treatment. A molecular change is not automatically a meaningful improvement in brain function.

Read the evidence ↗

01 / OVERVIEW

What is Semax?

Semax is a synthetic ACTH-fragment analogue studied in models of brain injury. [1]

02 / RESEARCH AIMS

Why it is studied.

The cited study examined gene regulation after experimental cerebral ischemia in rats, asking how the peptide affects biological responses to reduced blood flow. [1]

03 / RESEARCH MAP

Following the research question.

Researchers observed changes in immune-response and other gene-expression pathways. The molecular explanation remains incomplete; a single proven human pathway is not established here. [1]

Semax research map: ACTH-fragment analogue; Gene-expression changes; Rat ischemia modelRESEARCH MAP / SEMAX01ACTH-fragment analogue02Gene-expression changes03Rat ischemia model
Conceptual research map, not a molecular structure or a proven chain of clinical effects. [1]

04 / OBSERVED EFFECTS

What the evidence shows.

Rat transcriptome findings provide clues about biological responses after injury. They do not show that Semax improves memory in healthy people or establishes stroke-treatment efficacy. [1]

Study context

Animal study

Key distinction

Molecular endpoints

Uncertainty

Human benefit not established here

A selected-source overview, not a systematic review. Research findings are not verified effects of an independently supplied sample.

05 / SAFETY AND LIMITATIONS

Risks belong beside the findings.

FDA notes immunogenicity concerns and limited safety information for proposed administration routes. [2]

This guide reviews a preclinical study, not a comprehensive assessment of all regional clinical use. Species, timing and model differences limit translation.

06 / REFERENCES

Go to the source.

  1. Semax and immune-response genes after ischemia ↗

    Molecular Genetics and Genomics, 2017. Primary rat study.

  2. FDA — Safety concerns for certain compounded substances ↗

    Regulatory safety assessment; route and formulation matter.